We certainly recognize that we have a quality, worldwide service that's available right now when it comes to medical cannabis in this country. Certainly, with respect to the legislation in Bill C-45, we can see that we can build on that existing service.
What's imperative, however, is that we want to make sure consumers of medical cannabis will continue to have access to the product they need, and we will continue as well to monitor that situation very closely to make sure they always have access to the medication, to the products they use.
I may ask Ms. Bogden if there's anything else she wanted to add to that.